GRACE ELLIOTT: Open Payments
NPI 1114652005 · LA JOLLA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$607 in 17 payments from 11 companies in 2025. Trend: 2023 $39 · 2024 $624 · 2025 $607
Food & beverage: $607
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $251 |
| Phadia US Inc. | 1 | $94 |
| Novo Nordisk Inc | 2 | $57 |
| Hologic Sales and Service, LLC | 2 | $56 |
| Lilly USA, LLC | 1 | $30 |
| Gilead Sciences, Inc. | 1 | $24 |
| ViiV Healthcare Company | 1 | $22 |
| Exeltis, USA Inc. | 1 | $21 |
| Exact Sciences Corporation | 1 | $19 |
| PFIZER INC. | 1 | $19 |
Products named: BREZTRI, AIRSUPRA, ImmunoCAP, APTIMA, Wegovy, MOUNJARO, Saxenda, APRETUDE.
Industry payments across CA — which companies pay providers there.
